Literature DB >> 332344

Chemotherapy of the non-Hodgkin's lymphomas: the Stanford experience.

C S Portlock, S A Rosenberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 332344

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  6 in total

1.  Experimental models of lymphoproliferative disease. The mouse as a model for human non-Hodgkin's lymphomas and related leukemias.

Authors:  P K Pattengale; C R Taylor
Journal:  Am J Pathol       Date:  1983-11       Impact factor: 4.307

2.  Principles and present status of a prospective multicenter study on the clinical relevance of the Kiel classification.

Authors:  G Brittinger; U Schmalhorst; H Bartels; H H Fülle; H Gerhartz; G Gremmel; T Grisar; H J Grupp; U Gunzer; D Huhn; K M Koeppen; B Kubanek; H Leopold; H Löffler; G W Löhr; L Nowicki; U Rühl; M Schmidt; A Stacher; H Theml; K Lennert
Journal:  Blut       Date:  1981-09

3.  Diagnostic and therapeutic problems in non-Hodgkin lymphomas.

Authors:  K Musshoff; H Brücher
Journal:  Blut       Date:  1981-09

4.  [Non-Hodgkins's lymphomas - current aspects of clinical diagnosis and therapy].

Authors:  D Huhn
Journal:  Klin Wochenschr       Date:  1983-05-02

5.  Clinical and prognostic heterogeneity of non-Hodgkin lymphomas of high-grade malignancy.

Authors:  U Schmalhorst; H Bartels; I Boll; A Burger-Schüler; H Common; H H Fülle; M Graubner; R Heinz; D Huhn; H Leopold; P Meusers; L Nowicki; R Nürnberger; J Oertel; U Rühl; G Sieber; M Schmidt; A Schoengen; A Strassner; E W Schwarze; G Brittinger
Journal:  Blut       Date:  1981-09

6.  Prognostic factors in non-Hodgkin's lymphoma: the importance of symptomatic stage as an adjunct to the Kiel histopathological classification.

Authors:  R C Leonard; J Cuzick; I C MacLennan; R I Vanhegan; P H Mackie; C V McCormick
Journal:  Br J Cancer       Date:  1983-01       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.